PharmaShots | Incisive News in 3 Shots

Subscribe Now

Files

Pfizer and BioNTech's BNT162b2 Receives the US FDA's EUA to Prevent COVID-19

Pfizer and BioNTech's BNT162b2 Receives the US FDA's EUA to Prevent COVID-19

December 14, 2020

Genentech Files Complaint Against Centus Over Proposed Bevacizumab Biosimilar

Genentech Files Complaint Against Centus Over Proposed Bevacizumab Biosimilar

November 19, 2020

Sorrento Files IND for STI-1499 (COVI-GUARD) in Patients Hospitalized with COVID-19

Sorrento Files IND for STI-1499 (COVI-GUARD) in Patients Hospitalized with COVID-19

August 20, 2020

Sorrento's Partner Mabpharm Files NDA to the NMPA for Infliximab Biosimilar in China

Sorrento's Partner Mabpharm Files NDA to the NMPA for Infliximab Biosimilar in China

January 7, 2020

Chugai Files an Application to MHLW for an Additional Indication of Kadcyla (trastuzumab emtansine) as an Adjuvant Therapy for HER2-Positive Early Breast Cancer in Japan

Chugai Files an Application to MHLW for an Additional Indication of Kadcyla (trastuzumab emtansine) as an Adjuvant Therapy for HER...

September 2, 2019

ViiV Healthcare Files NDA for Cabotegravir + Edurant (rilpivirine) to the US FDA to Treat HIV-1 Infection in Adults

ViiV Healthcare Files NDA for Cabotegravir + Edurant (rilpivirine) to the US FDA to Treat HIV-1 Infection in Adults

April 30, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us